Latest ICR news
Researchers develop gene-editing platform to systematically decode histone function in mammalian cells
Scientists have developed a powerful new gene-editing platform that allows them, for the first time, to systematically test the function of key proteins in mammalian cells.
New clinical trial design could improve dose selection, maximising treatment efficacy and safety
Researchers have developed a new approach to help determine the optimal dose of cancer drugs, aiming to make early-stage clinical trials more transparent and better aligned with patient needs.
The ICR and The Royal Marsden partner with Mint Medical on roll out of global AI cancer imaging tool
The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust have announced a new licensing agreement with MedTech company Mint Medical, a Snke Company, to improve monitoring for patients with bone disease in advanced prostate cancer and multiple myeloma.
Targeting cancer cell DNA repair mechanism may make radiotherapy more effective
Scientists have uncovered a mechanism that helps cancer cells survive radiation, pointing to a potential new way to make treatment more effective.